[go: up one dir, main page]

AU2001283000A1 - Three dimensional structure of paramyxovirus hemagglutinin-neuraminidases and use thereof - Google Patents

Three dimensional structure of paramyxovirus hemagglutinin-neuraminidases and use thereof

Info

Publication number
AU2001283000A1
AU2001283000A1 AU2001283000A AU8300001A AU2001283000A1 AU 2001283000 A1 AU2001283000 A1 AU 2001283000A1 AU 2001283000 A AU2001283000 A AU 2001283000A AU 8300001 A AU8300001 A AU 8300001A AU 2001283000 A1 AU2001283000 A1 AU 2001283000A1
Authority
AU
Australia
Prior art keywords
neuraminidases
dimensional structure
paramyxovirus
hemagglutinin
paramyxovirus hemagglutinin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001283000A
Other languages
English (en)
Inventor
Y. Sidhakar Babu
Allen Portner
R. Scott Rowland
Toru Takomoto
Garry Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bath
University of St Andrews
St Jude Childrens Research Hospital
Biocryst Pharmaceuticals Inc
Original Assignee
University of Bath
University of St Andrews
St Jude Childrens Research Hospital
Biocryst Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Bath, University of St Andrews, St Jude Childrens Research Hospital, Biocryst Pharmaceuticals Inc filed Critical University of Bath
Publication of AU2001283000A1 publication Critical patent/AU2001283000A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
    • G16B15/30—Drug targeting using structural data; Docking or binding prediction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001283000A 2000-07-27 2001-07-27 Three dimensional structure of paramyxovirus hemagglutinin-neuraminidases and use thereof Abandoned AU2001283000A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22119900P 2000-07-27 2000-07-27
US60/221,199 2000-07-27
PCT/US2001/023623 WO2002010459A2 (fr) 2000-07-27 2001-07-27 Structure tridimensionnelle d'hemagglutine-neuraminidases de paramyxovirus et utilisation correspondante

Publications (1)

Publication Number Publication Date
AU2001283000A1 true AU2001283000A1 (en) 2002-02-13

Family

ID=22826783

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001283000A Abandoned AU2001283000A1 (en) 2000-07-27 2001-07-27 Three dimensional structure of paramyxovirus hemagglutinin-neuraminidases and use thereof

Country Status (3)

Country Link
US (1) US20020081572A1 (fr)
AU (1) AU2001283000A1 (fr)
WO (1) WO2002010459A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2475223A (en) * 2009-09-24 2011-05-18 Pasteur Institut A Paramyxoviridae family N protein-RNA complex in crystal form
CN107341854A (zh) * 2017-06-05 2017-11-10 杭州坤天自动化系统有限公司 沉浸式3d厂区地图自动生成方法、电子设备及存储介质
CN110240635B (zh) * 2019-06-10 2022-04-22 华中农业大学 检测新城疫病毒抗体的多肽及其elisa检测试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997009345A1 (fr) * 1995-09-08 1997-03-13 St. Jude Children's Research Hospital Purification de proteines de virus a partir de virosomes

Also Published As

Publication number Publication date
WO2002010459A3 (fr) 2003-02-27
US20020081572A1 (en) 2002-06-27
WO2002010459A2 (fr) 2002-02-07

Similar Documents

Publication Publication Date Title
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001296535A1 (en) High performance nanostructured materials and methods of making the same
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU2002213355A1 (en) Wireless asp systems and methods
AU2002255451A1 (en) Procaryotic libraries and uses
AU2001264258A1 (en) Nonwoven-fabric laminate and use thereof
AU2002211717A1 (en) Stresscopins and their uses
AU2001280179A1 (en) Production and use of octafluoropropane
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU2001261750A1 (en) Laminate and its use
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2002239933A1 (en) Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof
AU7458201A (en) Laminate and use thereof
AU2002230717A1 (en) Use of convergence-enabled dvd and web system
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002213429A1 (en) Antiviral methods and compounds
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001252627A1 (en) Polybenzasol fiber and use of the same
AU2002221353A1 (en) Suitcase structure and suitcase incorporating same
AU2001268236A1 (en) Use of aicar and related compounds
AU4432001A (en) Trityl-type compounds and their use
AU2001249692A1 (en) Phospholipid scramblases and methods of use thereof
AU2001283000A1 (en) Three dimensional structure of paramyxovirus hemagglutinin-neuraminidases and use thereof